Anti–IL-5 in Mild Asthma Alters Rhinovirus-induced Macrophage, B-Cell, and Neutrophil Responses (MATERIAL). A Placebo-controlled, Double-Blind Study-Reference-Cited by-同舟云学术

Anti–IL-5 in Mild Asthma Alters Rhinovirus-induced Macrophage, B-Cell, and Neutrophil Responses (MATERIAL). A Placebo-controlled, Double-Blind Study

Published:2019-02-15 Issue:4 Volume:199 Page:508-517
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Sabogal Piñeros Yanaika S.¹²^ORCID,Bal Suzanne M.¹²,van de Pol Marianne A.²,Dierdorp Barbara S.²,Dekker Tamara²,Dijkhuis Annemiek²,Brinkman Paul¹,van der Sluijs Koen F.²,Zwinderman Aeilko H.³,Majoor Christof J.¹,Bonta Peter I.¹,Ravanetti Lara¹²,Sterk Peter J.¹,Lutter René¹²

Affiliation:

1. Department of Respiratory Medicine

2. Department of Experimental Immunology (Amsterdam Infection & Immunity Institute), and

3. Department of Clinical Epidemiology, Bioinformatics, and Biostatistics, University of Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201803-0461OC

Reference37 articles.

1. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: The next steps toward personalized care